Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study

References

• HarveyPDBowieCRFriedmanJICognition in schizophreniaCurr Psychiatry Rep20013542342811559481
   PubMedGoogle Scholar
• GreenMFWhat are the functional consequences of neurocognitive deficits in schizophrenia?Am J Psychiatry199615333213308610818
   PubMed Web of Science ®Google Scholar
• HoeMNakagamiEGreenMFBrekkeJSThe causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approachPsychol Med201242112287229922475159
   PubMed Web of Science ®Google Scholar
• KodlCTSeaquistERCognitive dysfunction and diabetes mellitusEndocr Rev200829449451118436709
   PubMed Web of Science ®Google Scholar
• BoraEAkdedeBBAlptekinKThe relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysisPsychol Med20174761030104028032535
   PubMed Web of Science ®Google Scholar
• O’TuathaighCMWaddingtonJLMutant mouse models: phenotypic relationships to domains of psychopathology and pathobiology in schizophreniaSchizophr Bull201036224324520154202
   PubMed Web of Science ®Google Scholar
• BelangerMAllamanIMagistrettiPJBrain energy metabolism: focus on astrocyte-neuron metabolic cooperationCell Metab201114672473822152301
   PubMed Web of Science ®Google Scholar
• OwenOEMorganAPKempHGBrain metabolism during fastingJ Clin Invest19674610158915956061736
   PubMed Web of Science ®Google Scholar
• WilliamsonDHBatesMWPageMAKrebsHAActivities of enzymes involved in acetoacetate utilization in adult mammalian tissuesBiochem J1971121141475165621
   PubMed Web of Science ®Google Scholar
• ElwoodJCMarcoAVan BruggenJTLipid metabolism in the diabetic rat. IV. Metabolism of acetate, acetoacetate, butyrate, and mevalonate in vitroJ Biol Chem196023557357713820133
   PubMed Web of Science ®Google Scholar
• BentourkiaMTremblaySPifferiFRousseauJLecomteRCunnaneSPET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosisAm J Physiol Endocrinol Metab20092964E796E80119176356
   PubMed Web of Science ®Google Scholar
• PrabakaranSSwattonJERyanMMMitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stressMol Psychiatry20049768469764315098003
   PubMed Web of Science ®Google Scholar
• PettegrewJWKeshavanMSPanchalingamKAlterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopyArch Gen Psychiatry19914865635681898445
   PubMed Web of Science ®Google Scholar
• KeshavanMSPettegrewJWPanchalingamKSKaplanDBozikEPhosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophreniaArch Gen Psychiatry19914812111211131845229
   PubMed Web of Science ®Google Scholar
• DescoMGispertJDReigSCerebral metabolic patterns in chronic and recent-onset schizophreniaPsychiatry Res2003122212513512714176
   PubMed Web of Science ®Google Scholar
• TammingaCAThakerGKBuchananRLimbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndromeArch Gen Psychiatry19924975225301627043
   PubMed Web of Science ®Google Scholar
• YangJChenTSunLPotential metabolite markers of schizophreniaMol Psychiatry2013181677822024767
   PubMed Web of Science ®Google Scholar
• HuangYCLinPYLeeYβ-hydroxybutyrate, pyruvate and metabolic profiles in patients with schizophrenia: a case control studyPsychoneuroendocrinology2016731827448522
   PubMed Web of Science ®Google Scholar
• CunnaneSCCourchesne-LoyerAVandenbergheCCan ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer’s diseaseFront Mol Neurosci201695327458340
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental DisordersDSM-IV-TRWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• WangCHLiYYangJA randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophreniaSchizophr Res20131441–312913523352776
   PubMed Web of Science ®Google Scholar
• ZhuWZhangZQiJAdjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled studyNeuropsychiatr Dis Treat2014101317132325075190
   PubMed Web of Science ®Google Scholar
• NewcomerJWSecond-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature reviewCNS Drugs200519Suppl 1193
   PubMed Web of Science ®Google Scholar
• WHO collaborating centre for drug statistics methodologyATC/DDD Index2016 Available from: http://www.whocc.no/atc_ddd_index/Accessed January 15, 2016
   Google Scholar
• SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859Suppl 202233 quiz 34–57
   PubMed Web of Science ®Google Scholar
• ChouFHChouPSuTTQuality of life and related risk factors in a Taiwanese Village population 21 months after an earthquakeAust N Z J Psychiatry200438535836415144515
   PubMed Web of Science ®Google Scholar
• KaySROplerLALindenmayerJPReliability and validity of the positive and negative syndrome scale for schizophrenicsPsychiatry Res1988231991103363019
   PubMed Web of Science ®Google Scholar
• KeefeRSGoldbergTEHarveyPDGoldJMPoeMPCoughenourLThe Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batterySchizophr Res2004682–328329715099610
   PubMed Web of Science ®Google Scholar
• KeefeRSPoeMWalkerTMKangJWHarveyPDThe Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacityAm J Psychiatry2006163342643216513863
   PubMed Web of Science ®Google Scholar
• WangLJHuangYCHungCFThe Chinese version of the brief assessment of cognition in schizophrenia: data of a large-scale Mandarin-speaking populationArch Clin Neuropsychol201732328929628431029
   PubMed Web of Science ®Google Scholar
• WangLJLinPYLeeYValidation of the Chinese version of brief assessment of cognition in schizophreniaNeuropsychiatr Dis Treat2016122819282627826194
   PubMed Web of Science ®Google Scholar
• KeefeRSHarveyPDGoldbergTENorms and standardization of the brief assessment of cognition in schizophrenia (BACS)Schizophr Res20081021–310811518495435
   PubMed Web of Science ®Google Scholar
• CaiHLLiHDYanXZMetabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidoneJ Proteome Res20121184338435022800120
   PubMed Web of Science ®Google Scholar
• NenadicIDietzekMLangbeinKEffects of olanzapine on 31P MRS metabolic markers in schizophreniaHum Psychopharmacol2013281919323225665
   PubMed Web of Science ®Google Scholar
• Blesa-MalpicaGJohnstonDGBurrinJMOrskovHHeathABAlbertiKGDopaminergic control of ketogenesis in fastingClin Endocrinol (Oxf)19811454794847307278
   PubMed Web of Science ®Google Scholar
• McGavinJKGoaKLAripiprazoleCNS Drugs20021611779786 discussion 787–78812383035
   PubMed Web of Science ®Google Scholar
• AlbaughVLVaryTCIlkayevaOAtypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodentsSchizophr Bull201238115316620494946
   PubMed Web of Science ®Google Scholar
• O’GradaCDinanTExecutive function in schizophrenia: what impact do antipsychotics have?Hum Psychopharmacol200722639740617579928
   PubMed Web of Science ®Google Scholar
• BolstadIAndreassenOAGrooteIRHaatveitBServerAJensenJNo difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidolFront Hum Neurosci2015929626074803
   PubMed Web of Science ®Google Scholar
• KimEHowesODTurkheimerFEThe relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory: a dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazolePsychopharmacology2013227222122923271192
   PubMed Web of Science ®Google Scholar
• Yasui-FurukoriNKanedaASugawaraNTomitaTKanekoSEffect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patientsJ Psychopharmacol201226680681221616975
   PubMed Web of Science ®Google Scholar
• SuzukiHGenKInoueYAn unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophreniaProg Neuropsychopharmacol Biol Psychiatry201135116116821047544
   PubMed Web of Science ®Google Scholar
• KernRSGreenMFCornblattBAThe neurocognitive effects of aripiprazole: an open-label comparison with olanzapinePsychopharmacology2006187331232016810506
   PubMed Web of Science ®Google Scholar
• MolinaVLubeiroASotoOAlterations in prefrontal connectivity in schizophrenia assessed using diffusion magnetic resonance imagingProg Neuropsychopharmacol Biol Psychiatry20177610711528288855
   PubMed Web of Science ®Google Scholar
• BarchDMCeaserACognition in schizophrenia: core psychological and neural mechanismsTrends Cogn Sci2012161273422169777
   PubMed Web of Science ®Google Scholar
• BubberPTangJHaroutunianVMitochondrial enzymes in schizophreniaJ Mole Neurosci2004242315321
   Web of Science ®Google Scholar
• KashiwayaYTakeshimaTMoriNNakashimaKClarkeKVeechRLD-beta-hydroxybutyrate protects neurons in models of Alzheimer’s and Parkinson’s diseaseProc Natl Acad Sci U S A200097105440544410805800
   PubMed Web of Science ®Google Scholar
• RegerMAHendersonSTHaleCEffects of beta-hydroxybutyrate on cognition in memory-impaired adultsNeurobiol Aging200425331131415123336
   PubMed Web of Science ®Google Scholar
• ShimazuTHirscheyMDNewmanJSuppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitorScience2013339611621121423223453
   PubMed Web of Science ®Google Scholar
• Giraldo-ChicaMRogersBPDamonSMLandmanBAWoodwardNDPrefrontal-thalamic anatomical connectivity and executive cognitive function in schizophreniaBiol Psychiatry Epub2017928
   Google Scholar